Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
BMJ Open Gastroenterology|March 26, 2022
Metabolic dysfunction-related liver disease as a risk factor for cancerAlasdair Taylor, Moneeza K Siddiqui, Philip Ambery, et al.
JCI Insight|November 26, 2024
Longitudinal clinical and proteomic diabetes signatures in women with a history of gestational diabetesHeaseung Sophia Chung, Lawrence Middleton, Manik Garg, et al.
The Journal of Endocrinology|August 11, 2006
Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone productionAnthony P Coll, Martin Fassnacht, Steffen Klammer, et al.
Clinical Endocrinology|July 21, 2020
A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paragangliomaJames MacFarlane, Keat Cheah Seong, Chad Bisambar, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 7, 2021
Breast cancer in multiple endocrine neoplasia type 1 (MEN1)Seong Keat Cheah, Chad Ramese Bisambar, Deborah Pitfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Fumarate Metabolic Signature for the Detection of Reed Syndrome in HumansRuth T Casey, Mary A McLean, Benjamin G Challis, et al.
Human Molecular Genetics|August 8, 2002
A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanismBenjamin G Challis, Lynn E Pritchard, John W M Creemers, et al.
Cancer Discovery|April 17, 2023
A View on Drug Development for Cancer PreventionAndrew R Reynolds, Michele Moschetta, Alula R Yohannes, et al.
Endocrine Connections|August 9, 2017
Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and managementBenjamin G Challis, Andrew S Powlson, Ruth T Casey, et al.
JCO Precision Oncology|April 6, 2019
Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumours into clinical utilityRuth T Casey, Mary A McLean, Basetti Madhu, et al.
Pageof 4